Mid Atlantic Financial Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$346K Buy
2,381
+11
+0.5% +$1.61K 0.02% 603
2021
Q2
$313K Sell
2,370
-802
-25% -$105K 0.02% 649
2021
Q1
$407K Buy
3,172
+866
+38% +$107K 0.03% 503
2020
Q4
$275K Hold
2,306
0.02% 613
2020
Q3
$277K Buy
2,306
+204
+10% +$24.1K 0.02% 547
2020
Q2
$240K Buy
+2,102
New +$223K 0.02% 556

Other funds holding DGX

Mid Atlantic Financial Management's DGX Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Quest Diagnostics (DGX) stake by 0.46% in Q3 2021, buying an estimated $1.61K and bringing the position to 2,381 shares worth $346K. The position accounts for 0.02% of the portfolio, ranked #603.

Mid Atlantic Financial Management first reported a position in DGX in Q2 2020 and has held it in 6 quarters since. The position peaked at $407K in Q1 2021. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Mid Atlantic Financial Management held 2,381 shares of Quest Diagnostics worth $346K as of Q3 2021.
  • Mid Atlantic Financial Management bought 11 Quest Diagnostics shares in Q3 2021, an estimated $1.61K.
  • Quest Diagnostics made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #603 holding.
  • Mid Atlantic Financial Management first reported a position in Quest Diagnostics in Q2 2020 and has held it in 6 quarters since.
  • Mid Atlantic Financial Management's Quest Diagnostics position peaked at $407K in Q1 2021.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.